Written in EnglishRead online
Includes bibliographical references and index.
|Statement||edited by J. Claude Daubert, Eric N. Prystowsky, Alain Ripart.|
|Contributions||Daubert, J. Claude, Prystowsky, Eric N., Ripart, Alain.|
|LC Classifications||RC684.P3 P77 1997|
|The Physical Object|
|Pagination||x, 203 p. :|
|Number of Pages||203|
|LC Control Number||96046589|
Download Prevention of tachyarrhythmias with cardiac pacing
ISBN: OCLC Number: Description: x, pages: illustrations ; 24 cm: Contents: Section I: Experimental Data and New Concepts:; The Electrophysiological Basis for the Prevention of Tachyarrhythmias; New Insights into the Mechanisms and Management of the Long QT Syndromes with Emphasis on the Role of Heart Rate; Subthreshold Conditioning Stimuli Inhibit.
Prevention of Atrial Tachyarrhythmias by Cardiac Pacing AV synchronization The maintenance of AV synchrony is important for the prevention of AF. A number of studies have indicated a significant increase in the prevalence of AF in patients implanted with ventricular demand pacemak-ers for sinus node disease compared with patients in.
Written by world authorities on pacing and devices for cardiac care, this new full-color 3rd edition is the more practical than ever. Key Features Addresses the management of patients with a broad range of conditions, including sinus node disease, carotid sinus hypersensitivity, tachyarrhythmias, heart failure, and more.
This is the first book devoted solely to the rapidly expanding options to treat atrial tachyarrhythmias electrically. Electrical devices offer the promise of prevention and control of atrial tachyarrhythmias, with significant improvements in all health care professionals dealing with atrial fibrillation and other atrial tachyarrhythmias.
Abstract. Overdrive pacing was used for many years to prevent ventricular tachycardia and there are many reports of its effectiveness. Nevertheless, the use of overdrive pacing for most types of ventricular tachyarrhythmia has been abandoned. One notable exception is torsades de pointes, in which interventions that increase heart rate, including pacing, at least temporarily protect against.
As a result, there is a resurgence of research interest in antitachycardia pacing for prevention of atrial tachyarrhythmias. This paper briefly describes the basic aspects of antitachycardia pacing, reviews the data on the use of implantable antitachycardia devices for PSVT and the selection of patients, and assesses the current status of research on atrial pacing for prevention of paroxysmal atrial flutter.
Pacing the atria at high rates may prevent the conditions required for re-entry and thus prevent atrial fibrillation. Current research is based on triggered atrial pacing, and specific preventive and anti-tachycardia pacing systems are now available for patients with symptomatic paroxysmal atrial tachycardias that are not controlled by drugs.
Prevention of Tachyarrhythmias with Cardiac Pacing. Armonk, NY: Futura Publishing Co; pp. 99– Pavin D, Revault D'Allonnes G, Mabo P, et al. Left atrial and biatrial pacing. In: Israel CW, Barold SS, editors. Advances in the Treatment of Atrial Tachyarrhythmias: Pacing.
Therapeutic strategies to control the tachyarrhythmias often cause SND and result in the need for pacemaker therapy (Fig.
On the other hand, long sinus pauses occurring following tachycardia episodes can be reversible in some patients once the tachyarrhythmia is eliminated, thus obviating the need for pacing. Prevention with pacing The electrophysiological basis for the prevention of tachyarrhythmias. In: Daubert JC, Prystowsky EN, Ripart A, eds.
Prevention of tachyarrhythmias with cardiac pacing. Armonk, NY: Futura Publishing, The ABC of interventional cardiology is edited by Ever D Grech and will be published as a book in autumn.
In fact, the ability to terminate a tachycardia with pacing stimuli has become a part of the clinical definition of reentry.(2) Although this chapter will focus on the use of permanent pacemakers for the termination of tachycardias, other strategies for the use of pacing in patients with tachyarrhythmias exist.
The prevention of bradycardia by. While bringing into focus the major advances in cardiac pacing over the last years this book places particular emphasis on new techniques for the treatment of congestive heart failure.
Other topics include new and unusual indications for pacemakers, the clinical aspects of expanding pacemaker memory and stored electrograms in the diagnosis. cardiac arrest with profound bradycardia (if used early) pulseless electrical activity due to drug overdose, acidosis, or electrolyte abnormalities; overdrive pacing for refractory tachyarrhythmias after failure of electrical cardioversion and drug therapy.
Contraindications to TCP include: severe hypothermia; prolonged bradyasystolic cardiac. Atrial pacing periablation for prevention of paroxysmal atrial fibrillation. Circulation. ; – Crossref Medline Google Scholar; 26 Delfault P, Saksena S, Prakash A, et al.
Long-term outcome of patients with drug refractory atrial flutter and fibrillation after single and dual-site right atrial pacing for arrhythmia prevention. Chapter 2. Clinical Diagnosis of Atrial Tachyarrhythmias inPacemaker Patients (C. Lam, B. Wilkoff). Section 2. Prevention of Atrial Tachyarrhythmias byConventional Antibradycardia Pacing.
Chapter 3. Prevention of Atrial Tachyarrhythmias by ConventionalPermanent Antibradycardia Pacing. tachyarrhythmias, in particular atrial fibrillation (AF), ventricular ar-rhythmias, and sudden cardiac death (SCD).
Moreover, considering the crucial role of the increased sympathetic system activation in the pathogenesis of various cardiac arrhythmias, available data suggest that antihypertensive therapies, such as renal sympathetic dener.
This volume reviews current pathophysiologic concepts and describes state-of-the-art techniques for management of cardiac arrhythmias in children and young adults with congenital heart disease. The book provides a thorough understanding of cardiac electrophysiology and detailed technical information on catheter ablation, pacemakers, and implantable defibrillators.
Factors that influence the incidence of tachyarrhythmias include the underlying rhythm disturbance and cardiac disease, metabolic derangement, drugs (e.g., digoxin), and the strength of shock.
Histologic injury to the myocardium is rare when the starting power for cardioversion is set for J/kg. 25 Systemic and pulmonary emboli are extremely. Get this from a library. The fifth decade of cardiac pacing. [S Serge Barold; Jacques Mugica;] -- While bringing into focus the major advances in cardiac pacing over the last years this book places particular emphasis on new techniques for the treatment of congestive heart failure.
Other. Cardiac arrhythmias are common in the critical care setting. Many arrhythmias detected are benign, may occur in healthy individuals and require no investigation or treatment, for example, sinus tachycardia, sinus bradycardia, Mobitz type I second-degree AV block or premature atrial and ventricular beats.
prevention and termination of tachyarrhythmias Permanent pacing may prevent or terminate certain ventricular and supraventricular arrhythmias in. The present status of the use of electrical pacing to treat tachyarrythmias is reviewed. The pathogenesis of arrythmia formation, methods of pacing, response of specific tachyarrhythmias to pacing and the clinical application of pacing to terminate and suppress tachyarrhythmias are delineated.
Cardiovascular Medicine: Cardiac Arrhythmias, Pacing and Sudden Death covers every aspect of cardiac arrhythmias, from cardiac signs and symptoms. Immediate reinitiation of atrial tachyarrhythmia (IRAT) is an important cause of failure to maintain sinus rhythm.
IRAT prevention by overdrive pacing has not been evaluated in a prospective. Rapid advancements in cardiac electrophysiology require today’s health care scientists and practitioners to stay up to date with new information both at the bench and at the fully revised 7th Edition of Cardiac Electrophysiology: From Cell to Bedside, by Drs.
Douglas Zipes, Jose Jalife, and William Stevenson, provides the comprehensive, multidisciplinary coverage you need. This book offers updated explanations for the electrophysiological basis of many arrhythmias, with an emphasis on atrial fibrillation. Distinguished experts address specific topics in their fields, gathering current, relevant information in a clear and user-friendly format.
It reviews different aspects of bradyarrhythmias and discusses various pacing approaches to terminating tachyarrhythmias. It has been suggested that biventricular pacing might reduce the risk of developing AF with pacing.
4 Post hoc analyses 5 and small studies, 6 however, did not find a reduction in the incidence of AF with cardiac resynchronization therapy compared with right ventricular pacing or standard medical care.
In contrast, the systematic prevention of. The goal of APART is the assessment of the therapeutic and preventive stimulation algorithms of the Medtronic AT and following devices in patients with atrial tachyarrhythmias and an indication for cardiac pacing according to the German guidelines.
Medication is controlled throughout the study with a beta-blocker as the only antiarrhythmic drug. The Reduction And Prevention of Tachyarrhythmias and Shocks Using Reduced Ventricular Pacing with Atrial Algorithms Study (The RAPTURE Study, identifier NCT) was designed, written, and executed by the academic investigators.
As biventricular pacing may also diminish the susceptibility to ventricular tachyarrhythmias, this may have introduced a bias,22 23 although no significant difference was seen in the prevalence of cardiac resynchronisation therapy between the patients with and without ventricular arrhythmias.
Furthermore, patients with a recent myocardial. Heart Failure: Clinical Performance and Quality Measures JACC | PDF | Key Points to Remember | News Story; High Blood Pressure: Clinical Performance and Quality Measures JACC | PDF | News Story; Cardiac Rehabilitation: Clinical Performance and Quality Measures JACC | PDF | Key Points to Remember | News Story; Adults With ST-Elevation and Non–ST-Elevation Myocardial.
The history of cardiac pacing device implantation began inwhen Seymour Furman utilised temporary transvenous pacing as therapy for complete heart block. 1 Ake Senning implanted the first pacemaker as an asynchronous ventricular device 2 in The indications for cardiac pacing therapy have been expanding to include patients with different heart rhythm disorders, including sinus node.
The RAPTURE Study will determine whether dual chamber defibrillators with atrial prevention and termination therapies, minimized ventricular pacing, and remote monitoring will reduce the rate of inappropriate shocks and improve quality of life compared to optimally programmed back-up pacing only single chamber ICDs when used for primary.
CONCLUSIONS: Ventricular tachyarrhythmias requiring ICD therapy were common in patients with cardiac sarcoidosis, with an estimated incidence rate of 15% per year.
Longer follow-up, left ventricular systolic dysfunction, and complete heart block were associated with VT/VF. In 43 patients (34 percent), with a mean age of 40±19 years, defibrillators were implanted for secondary prevention after either resuscitation from cardiac arrest (with documented ventricular.
However, the study was not powered to make statistical comparisons for any single component of the primary endpoint and could not make conclusions on how implantation of a DC-ICD directly affected rates of inappropriate therapy or mortality.
11 The Reduction And Prevention of Tachyarrhythmias and Shocks Using Reduced Ventricular Pacing with. eBook Cardiac Pacing And Device Therapy Uploaded By Clive Cussler, cardiac pacing and device therapy david r ramsdale archana rao isbn kostenloser versand fur alle bucher mit versand und verkauf duch amazon cardiac pacing and device therapy is a practical reference for all those involved in the day to day care of.
Sarcoidosis is an inflammatory granulomatous disease that can affect any organ. Systemic sarcoidosis is known to affect young adults, with a second peak in women >50 years of age, as demonstrated in Scandinavian and Japanese studies. 1 – 4 In the US, the lifetime risk of sarcoidosis is % for black people and % for white people.
1 The incidence of cardiac involvement has been. Vadim VF, Ilya TL. Is beta3-adrenergic receptors a new target for treatment of post-infarct ventricular tachyarrhythmias and prevention of sudden cardiac death. Heart Rhythm ; Heart rate variability: standards of measurement, physiological interpretation and clinical use.
Task Force of the European Society of Cardiology. Left atrial pacing may not only be valuable in assessing the true atrial arrhythmia burden but would be useful for AF prevention by reducing interatrial conduction delay. 4,5 The phenomenon of interatrial conduction delay in a population with implantable pacemakers and pacemaker defibrillators may be far more prevalent than recognized and.
Outcomes of patients with nonischemic cardiomyopathy and low ejection fraction implanted with an implantable cardioverter-defibrillator (ICD) or cardiac resynchronization therapy with a defibrillator (CRT-D), especially in contemporary, real-life cohorts, are not fully understood.Placement of a left ventricular assist device (LVAD) has been described to compromise implantable cardioverter-defibrillator (ICD) defibrillation threshold (DFT).
Elevated DFT will have negative consequences and increases the risk of ineffective ICD shocks, morbidity, and mortality. DFT testing is not routinely performed in clinical practice, despite this fact.